Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.

5/9/2013, Thursday

FOR RELEASE 5/9/2013, Thursday

Alex Kelly Joins Bausch + Lomb as Vice President Investor Relations

ROCHESTER, NY — Bausch + Lomb, the global eye health company, today announced that Alex Kelly has joined the company as vice president, Investor Relations, reporting to the company’s president and chief financial officer, Bob Bertolini.  In this capacity, Kelly will serve as the primary point of contact for the investment community.  

“I have had the pleasure of working closely with Alex over many years,” said Bertolini.  “He’s a world-class executive and we are very fortunate to have him join the Bausch + Lomb team.”  

Kelly joins us from Merck & Co., where he served most recently as vice president, Investor Relations.  Prior to Merck, he was group vice president of Global Communications and Investor Relations at Schering-Plough.  Earlier in his career, Kelly held senior Investor Relations roles with Novartis and Pharmacia & Upjohn.  A pharmacist by training, he started his career in Pharmaceutical sales at the Upjohn Company where he was later a district sales manager. 

“Having seen the progress Bausch + Lomb has made in transforming itself over the last three years, this is an exciting time to join the company,” said Kelly.  “I look forward to working with the management team to help Bausch + Lomb realize its vision of becoming the best global eye health company.”

Adam Grossberg, vice president of Global Communications will transition his Investor Relations responsibilities to Kelly, and take on added responsibility for the company’s Global Branding, Advertising & Digital Initiatives.

About Bausch + Lomb

Bausch + Lomb is a leading global eye health company that is solely focused on protecting, enhancing, and restoring people’s eyesight.  Our core businesses include ophthalmic pharmaceuticals, contact lenses and lens care products, and ophthalmic surgical devices and instruments.  We globally develop, manufacture and market one of the most comprehensive product portfolios in our industry, which are available in more than 100 countries.  Founded in 1853, our company is headquartered in Rochester, NY, and employs more than 11,000 people worldwide. 

#  #  #

News Media Contact:

Elizabeth Murphy

Global Communications

(585) 338-8528 or

Investor Relations Contact:

Dan Ritz

Investor Relations

(585) 338-5802 or


Number of views (2982)/Comments (0)